Plasmin induces apoptosis of aortic valvular myofibroblasts
- 1 April 2010
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 221 (1) , 37-48
Abstract
Previous studies have described remodelling of the extracellular substratum by matrix metalloproteinases (MMPs) in aortic valves. However, involvement of the fibrinolytic system has not yet been analysed. We hypothesized that plasminogen and plasminogen activator(s) are present in aortic valves and that plasminogen activation could induce the degradation of adhesive proteins and apoptosis of the valvular myofibroblasts. We employed ELISA, western blotting, fibrin‐agar zymography, and immunochemistry to detect components of the plasminogen activation system, in samples of aortic valves and valvular myofibroblasts in primary culture. Using myofibroblast cultures, real‐time measurement of plasminogen activation was performed in the absence and presence of inhibitors (amiloride, ε‐aminocaproic acid, and an MMP inhibitor); the degradation of fibronectin was visualized on western blots; and the apoptotic process was assessed by detection of phosphatidylserine exposure (binding of FITC‐annexin V) and DNA fragmentation (TUNEL and ELISA). We demonstrate that a time‐ and plasminogen concentration‐dependent generation of plasmin occurs on the surface of cultured valvular myofibroblasts expressing both u‐PA and t‐PA. Only u‐PA appears to activate plasminogen as t‐PA is essentially found in complex with PAI‐1. Plasmin‐dependent degradation of pericellular proteins, such as fibronectin, leads to cell detachment and apoptosis. In conclusion, various proteins of the fibrinolytic system are synthesized in vitro by cultured myofibroblasts from aortic valves, leading to plasmin‐dependent cell detachment‐induced apoptosis, a biological process named anoikis. The presence of plasminogen in aortic valves suggests that this process may be operating in vivo and may participate in valvular tissue remodelling, as also suggested by the finding of apoptotic cells in valvular tissue. This is the first demonstration of the presence and potential role of enzymes of the fibrinolytic system in aortic valves. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- Inserm
- Inserm-DGRSRT
- Fédération Française de Cardiologie
This publication has 36 references indexed in Scilit:
- Targeting vascular calcification: softening-up a hard targetCurrent Opinion in Pharmacology, 2009
- Plasminogen Activation–Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast ApoptosisAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Biologic Features (Inflammation and Neoangiogenesis) and Atherosclerotic Risk Factors in Carotid Plaques and Calcified Aortic Valve StenosisAmerican Journal of Clinical Pathology, 2006
- Protease Nexin-1 Inhibits Plasminogen Activation-induced Apoptosis of Adherent CellsJournal of Biological Chemistry, 2004
- Pericellular plasmin induces smooth muscle cell anoikisThe FASEB Journal, 2003
- Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle CellsJournal of Biological Chemistry, 2003
- Plasmin Abrogates αvβ5-Mediated Adhesion of a Human Keratinocyte Cell Line (HaCaT) to VitronectinExperimental Cell Research, 1995
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Conformational Studies of Human Plasminogen and Plasminogen Fragments: Evidence for a Novel Third Conformation of PlasminogenBiochemistry, 1994
- Plasmin cleavage of vitronectin Identification of the site and consequent attenuation in binding plasminogen activator inhibitor‐1FEBS Letters, 1991